# Delivery Order #SPE2D626F7QA4

DLA Orders Matrigel for Human Stem Cell Research

**Buyer:** Defense Logistics Agency

**Award Amount:** $561.94
**Ceiling:** $561.94

**Awarded:** July 21, 2026
**Period of Performance:** Jul 21, 2026 - Aug 11, 2026

**Identifier:** SPE2D626F7QA4
**NAICS:** 423450

This delivery order under the Defense Logistics Agency’s existing indefinite-delivery, indefinite-quantity laboratory-supplies contract provides VWR International, LLC, a laboratory products and services supplier, with a short-term order for a five-milliliter vial of human embryonic stem cell-qualified Matrigel matrix. The specialized cell-culture material supports laboratory research and related scientific work; the order contributes to DLA’s broader effort to supply laboratories with needed materials. The order was placed through the parent contract, which was described as competitively awarded; no separate competition or sole-source justification is provided for this order. Its performance period runs from late July to mid-August 2026. No acquisition program, subcontractor, or specific prior contract beyond the parent vehicle is identified.

### Description

4572453117!MATRIGEL HESC-QUALIF MATRX 5ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2D626F7QA4_9700_SPE2DE22D0007_9700)
